These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 7883977

  • 21. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW, Ren SG, Melmed S.
    Ann N Y Acad Sci; 1998 May 01; 840():162-73. PubMed ID: 9629248
    [Abstract] [Full Text] [Related]

  • 22. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.
    Stefana B, Ray DW, Melmed S.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12502-6. PubMed ID: 8901611
    [Abstract] [Full Text] [Related]

  • 23. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C, Zatelli MC, Melmed S.
    J Clin Invest; 2000 Dec 29; 106(11):1417-25. PubMed ID: 11104795
    [Abstract] [Full Text] [Related]

  • 24. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S, Kageyama K, Sugiyama A, Ishigame N, Niioka K, Suda T, Daimon M.
    Mol Cell Endocrinol; 2014 Aug 25; 394(1-2):37-46. PubMed ID: 25011056
    [Abstract] [Full Text] [Related]

  • 25. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
    Bousquet C, Melmed S.
    J Biol Chem; 1999 Apr 16; 274(16):10723-30. PubMed ID: 10196143
    [Abstract] [Full Text] [Related]

  • 26. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
    Bousquet C, Ray DW, Melmed S.
    J Biol Chem; 1997 Apr 18; 272(16):10551-7. PubMed ID: 9099700
    [Abstract] [Full Text] [Related]

  • 27. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H.
    J Clin Invest; 1993 Dec 18; 92(6):2790-5. PubMed ID: 8254033
    [Abstract] [Full Text] [Related]

  • 28. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro.
    van Wijk PA, Rijnberk A, Croughs RJ, Meij BP, Mol JA.
    Eur J Endocrinol; 1998 Mar 18; 138(3):309-15. PubMed ID: 9539306
    [Abstract] [Full Text] [Related]

  • 29. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
    Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD, Melmed S.
    J Clin Endocrinol Metab; 2003 Feb 18; 88(2):858-63. PubMed ID: 12574225
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mimecan in pituitary corticotroph cells may regulate ACTH secretion and the HPAA.
    Ma QY, Zhang XN, Jiang H, Wang ZQ, Zhang HJ, Xue LQ, Chen MD, Song HD.
    Mol Cell Endocrinol; 2011 Jul 20; 341(1-2):71-7. PubMed ID: 21664248
    [Abstract] [Full Text] [Related]

  • 32. Maternal leukemia inhibitory factor (LIF) promotes fetal neurogenesis via a LIF-ACTH-LIF signaling relay pathway.
    Simamura E, Shimada H, Higashi N, Uchishiba M, Otani H, Hatta T.
    Endocrinology; 2010 Apr 20; 151(4):1853-62. PubMed ID: 20160138
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    J Clin Invest; 1995 Sep 20; 96(3):1319-27. PubMed ID: 7657807
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.